Safinamide New Drug Application (NDA) Submitted to the US Food and Drug Administration (FDA) - 06/03/2014

Safinamide New Drug Application (NDA) Submitted to the US Food and Drug Administration (FDA) (via PR Newswire)

MILAN, May 29, 2014 /PRNewswire/ -- Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., an international pharmaceutical company strongly committed to the…